BDMP. See Birth Defects Monitoring Program

Behavioral changes, subtle, 73-74

Behavioral Risk Factor Surveillance System, 106

Benzene, 19

Beta probabilities, 21

Biologically effective dose. See Dose

Biologic markers, 17, 20, 33, 51, 56-58, 62, 81-84.

See also Sampling, personal cost of, 81

validating, 56, 58, 82, 86-87

Biologic Markers in Immunotoxicology,81

Birth defects. See Congenital anomalies

Birth Defects Monitoring Program, 105, 108-109, 163-165

Blood samples. See Sampling, personal

Bootstrap procedure, 141-142

Breathing zone measurements, 38-39

Breath samples. See Sampling, personal

Bronchitis

acute, in children, 70

chronic, 18, 72

C

Cancer Incidence Reporting System (Canada), 123

Cancers, 15, 23, 46, 68-69, 80

endometrial carcinoma, 14

hepatic angiosarcoma, 23

laryngeal, 147

leukemia, 19

lung, 22-24, 73, 170

mesothelioma, 19

stomach, 14

Carbon monoxide, 39

Cardiac defects, 78

Cardiovascular disease, 6, 15, 18

Case-cohort studies, 19, 148

Case-control studies, 17-19, 115, 148, 176

Case-crossover studies, 148

Case reports, 13

Causality, inferring. See Epidemiology studies

Census data, 15-16

Centers for Disease Control and Prevention, 126, 163-164, 168

Central nervous system (CNS) complications. See Neurologic symptomatology

CERCLA. See Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA)

Chemicals

agricultural (See Herbicides; Pesticides)

mixed, 50-51, 54, 61-62, 69

synthetic organic, 7, 100

volatile organic, 41, 74

xenobiotic, 50, 80

Children, susceptibility of, 85

Chlorine gas, 44, 112

Chromium, 46

Classification errors. See Misclassification

Cleaning products, 39

Clean Water Act, 102

Cleft lip and palate, 164-165

CNS. See Neurologic symptomatology

Coefficients of variation, 83

Cohort studies, 17-18, 114, 176.

See also Case-cohort studies

Complex mixtures. See Chemicals, mixed

Comprehensive Environmental Response, Compensation, and Liability Act of 1980, 116

Confidence bounds, 22

Confidentiality issues, 120-123

Confounding factors, 5-6, 15-16, 19, 22, 50, 83, 120, 134, 174

Congenital anomalies, 2, 78-79, 162-163, 167-168

Congenital Malformations Surveillance Report, 168

Consumer products, measuring concentrations of, 38-39

Cox proportional hazard model, 144

Cross-sectional surveys, 19-20, 114

Croup attacks, 71



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement